Davenport, Iowa-based dermatologist Ravindra Kumar Gangadhariah, MD, has agreed to pay a $1,000 penalty and undergo additional training after being accused of unsafe practices, Iowa Capital Dispatch reported Jan. 5.
Category: ROOT
New Jersey earmarks $15M for healthcare facilities that offer abortion services
New Jersey has set aside $15 million for healthcare facilities that offer a full spectrum of reproductive care to use for facility upgrades and security enhancements.
UCHealth and Intermountain partnering to form integrated network
Salt Lake City-based Intermountain Healthcare and Colorado Springs, Colo.-based UCHealth are forming a joint venture clinically integrated network, Intermountain said in a Jan. 5 news release.
8 Ohio medical updates
ASCs and gastroenterology practices have been taking off in Ohio, with several updates in the state since Nov. 22.
J&J consumer health arm files for IPO, moves closer to spinoff
Johnson & Johnson filed an initial public offering with the U.S. Securities and Exchange Commission for its consumer health unit, Kenvue, moving closer toward a spinoff, Bloomberg reported Jan. 4.
Staffing shortages spur Massachusetts hospital to divert ambulances
Framingham, Mass.-based MetroWest Medical Center diverted local ambulances from its hospital the past three weekends, citing staffing issues, the Framingham Source reported Jan. 4.
10 states with the highest risk of rural hospital closures
Rural hospitals have been facing immense financial pressures as they deal with rising inflation and the COVID-19 pandemic.
Virtual health platform built with Epic snags $27M
KeyCare, a virtual care platform built with Epic, raised $27 million in its series A financing round.
FDA director of medical supply unit is 'over the moon' for cybersecurity measures
The director of the FDA’s medical supply division praised the recently passed spending bill for its “total product life-cycle approach” and cybersecurity measure allowances, Politico reported Jan. 3.
Paxlovid use ebbs amid lack of funds, unclear rebound risk
Millions of Paxlovid packets haven’t been used, which could be tied to COVID-19 rebound risks, less federal funds and diminishing public concern about the pandemic, according to an article published Jan. 3 in Nature.
